Longitudinal study of the effect of PR-fampridine walking and quality of life in people with severe MS-related walking impairment

被引:0
|
作者
Ewe, R. A. L. [1 ]
Farrell, R. [2 ,3 ]
Louissaint, H. [3 ]
Bleasdale, H. [3 ]
Bull, K. [3 ]
Beare, B. [3 ]
Allen, J. [3 ]
机构
[1] UCL, Sch Med, London, England
[2] Univ Coll London Hosp, Inst Neurol, London, England
[3] Univ Coll Hosp NHS Fdn Trust, London, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1307
引用
收藏
页码:691 / 691
页数:1
相关论文
共 50 条
  • [1] PR-Fampridine improves walking and quality of life in people with severe MS-related walking impairment
    Ewe, R.
    Louissaint, H.
    Bleasdale, H.
    Bull, K.
    Farrell, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 332 - 332
  • [2] PR-FAMPRIDINE IMPROVES WALKING SPEED AND QUALITY OF LIFE IN MS
    Ewe, Renee
    Louissaint, Hannah
    Bull, Kate
    Allen, Joanne
    Farrell, Rachel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A45 - A45
  • [3] PR-Fampridine improves walking and quality of life in people with MS. A pragmatic observational study
    Flisher, L.
    Christofi, G.
    Koch, M.
    Wilkinson, H.
    Norman, S.
    Stevenson, V.
    Farrell, R.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 1004 - 1004
  • [4] Safety, Quality Of Life, and Walking Ability with PR-Fampridine Treatment in Clinical Practice in France: Interim Results of The LIBERATE Study
    Yeh, M.
    Neau, J. P.
    Castelnovo, G.
    Soisson, T.
    Kwiatkowski, A.
    McNeill, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 805 - 806
  • [5] Health-related quality of life improved in people with multiple sclerosis who had clinically meaningful changes in walking ability with PR-Fampridine: Post hoc analysis of enhance
    Hobart, J.
    Hupperts, R.
    Linnebank, M.
    Acosta, C.
    McNeill, M.
    Lima, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 452 - 452
  • [6] MS PATIENTS' PERCEPTION OF THE EFFECTS OF PR-FAMPRIDINE ON WALKING DISORDERS AND DAILY LIFE: RESULTS FROM AN OBSERVATIONAL STUDY CONDUCTED VIA AN ONLINE PATIENT COMMUNITY
    Simon, O.
    Wilczynski, O.
    Jomaa, K.
    VALUE IN HEALTH, 2018, 21 : S353 - S353
  • [7] The impact of walking impairment on work and quality of life in MS patients
    Larkin, A.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (05) : S57 - S57
  • [8] QUALITY OF LIFE AMONG PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH PROLONGED-RELEASE FAMPRIDINE 10 MG TABLETS FOR WALKING IMPAIRMENT
    Liu, Y.
    McNeill, M.
    Lee, A.
    Zhong, J.
    Mehta, L. R.
    VALUE IN HEALTH, 2014, 17 (07) : A401 - A402
  • [9] Effects of Walking on Quality of Life Among Lung Cancer Patients A Longitudinal Study
    Lin, Yi-Yun
    Liu, Megan F.
    Tzeng, Jann-Inn
    Lin, Chia-Chin
    CANCER NURSING, 2015, 38 (04) : 253 - 259
  • [10] Walking, quality of life, and safety with prolonged-release fampridine treatment in clinical practice: Interim results of the liberate study
    Schmidt, S.
    Oschmann, P.
    Neau, J. P.
    Castelnovo, G.
    Wang, P.
    Barbato, L.
    Mahadavan, L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E21 - E21